India's cheap weight-loss drugs could reshape global obesity fight
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Similar Stories
Related coverage based on topic and tags
India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value - Reuters
India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value Reuters
July 9, 2026 at 04:54 AMIndia's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters
India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice Reuters
July 9, 2026 at 12:23 PMThe weight loss pill that you can now buy in the UK
All the you need to know about the weight loss pill Wegovy being available in the UK.
July 6, 2026 at 06:58 PMNovo Nordisk launches weekly insulin shot Awiqli in India - Reuters
Novo Nordisk launches weekly insulin shot Awiqli in India Reuters
July 9, 2026 at 06:23 AMSouth African regulators issue recall of Ozempic copies - Reuters
South African regulators issue recall of Ozempic copies Reuters
July 9, 2026 at 09:14 PMFrom mouthwash to hair dye: How weight-loss jabs are changing shopping habits
The BBC looks at how spending habits have shifted as users report feeling less hungry.
July 7, 2026 at 11:11 PM